This recall has sparked concerns over the use of unregulated ingredients sourced from a factory in India,

raising questions about the effectiveness of oversight in the pharmaceutical industry. Despite the FDA’s assurance that the risk

is minimal, this alarming recall serves as a wake-up call for consumers to double-check their medication.

Here’s everything you need to know to protect yourself.

A recall has been issued for 600,000 bottles of a popular blood pressure medication following an FDA oversight. The medication,

Ramipril capsules in dosages of 2.5mg, 5mg, and 10mg, is being pulled from shelves due to concerns over potential

contamination linked to ingredients sourced from an unregulated manufacturer.

Ramipril is typically prescribed to treat high blood pressure by relaxing blood vessels and reducing heart pressure,

often following a heart attack. The issue stems from an ingredient used by a factory in India, which failed to properly vet its suppliers. Although the

FDA has stated that the risk of harm is low, the recall is being carried out as a precautionary measure.

As of now, no adverse effects have been reported.

If you have one of the affected bottles, it’s recommended that you dispose of it.

The recalled medications were produced by Lupin Pharmaceuticals and are available in 2.5mg, 5mg, and 10mg strengths.

The affected bottles have sell-by dates extending to July 2026 and were sold in quantities of 90, 100, or 150 capsules. Be sure to check your supply to ensure you don’t have a recalled batch.

In conclusion, while the FDA has deemed the risk of contamination to be low, the recall of 600,000 bottles of Ramipril capsules is a precautionary measure to ensure consumer safety. If you are currently using this medication, it’s crucial to check your bottles for

the affected batch numbers and discard any recalled products. Staying informed and vigilant can help prevent any potential health risks.

If you have concerns or questions about the recall, contact your healthcare provider for further guidance.

Please SHARE this article with your family and friends on Facebook.